It is sometimes difficult to be inspired when trying to write a persuasive essay, book report or thoughtful research paper. Often of times, it is hard to find words that best describe your ideas.
VIPessays now provides a database of over 150,000 quotations and proverbs from the famous inventors, philosophers, sportsmen, artists, celebrities, business people, and authors that are aimed to enrich and strengthen your essay, term paper, book report, thesis or research paper.
Try our free search of constantly updated quotations and proverbs database.
Letter "J" » Jami Rubin Quotes
«Expectations are at absolute rock-bottom levels. So this is huge. If they actually achieve it, it does change things.»
«Are they going bankrupt? No. But they had a string of bad news like I've never seen before. Bad news has become a norm to the company.»
«Though this news is clearly a disappointment, we believe that the damage is largely done and the 10 percent decline in the stock price fully compensates for the approximately 8 percent reduction in the earnings outlook for next year.»
«They're not going to make anything, but neither will they lose anything because they're not selling in those countries anyway. So it's a good public deed on their part, which is why I think most of this is public relations.»
«This is in response to a very challenging environment. I would expect broader cuts to be announced within the sales force, marketing, general and (administration) as well as R&D over the longer run.»
«We do this all the time. We pay them for their time. Sometimes they do conference calls. Sometimes they prepare slide shows.»
«In addition, we think completion of the company's consent decree obligations is a major psychological positive that could also have financial implications, as spending on consultants and inspections declines.»
«Recent launches have significantly larger commercial potential than the previous cycle?and [are] likely to drive improving growth prospects post-2006.»
«Approximately 50% of the cases are filed in the federal court, where standards for scientific evidence are far more rigorous.»
«Based on improving new product visibility, benefits from restructuring initiatives, and near-term volume boost from Medicare Part D supports our Attractive rating for the U.S. pharmaceutical sector.»